Dow Jones

38,864.57

0.22%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
Nuo Therapeutics Inc (QB) (AURX)
Nuo Therapeutics Inc (QB) (AURX) Noticias

AURX

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:AURX

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
11/06/2024	15:26	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
22/05/2024	11:40	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
21/05/2024	14:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
15/05/2024	16:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:AURX	Nuo Therapeutics Inc (QB)
14/02/2024	12:58	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:AURX	Nuo Therapeutics Inc (QB)
12/02/2024	16:33	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:AURX	Nuo Therapeutics Inc (QB)
20/12/2023	13:18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:AURX	Nuo Therapeutics Inc (QB)
15/11/2023	08:37	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:AURX	Nuo Therapeutics Inc (QB)
15/05/2023	16:10	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
17/04/2023	05:08	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:AURX	Nuo Therapeutics Inc (QB)
14/11/2022	17:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:AURX	Nuo Therapeutics Inc (QB)
20/10/2022	07:36	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
20/10/2022	07:34	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
30/08/2022	07:16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AURX	Nuo Therapeutics Inc (QB)
10/08/2022	12:29	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
05/07/2022	07:03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
05/07/2022	07:02	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:AURX	Nuo Therapeutics Inc (QB)
19/05/2022	15:35	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:AURX	Nuo Therapeutics Inc (QB)
27/04/2022	15:20	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:AURX	Nuo Therapeutics Inc (QB)
31/03/2022	15:47	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:AURX	Nuo Therapeutics Inc (QB)
21/03/2022	09:30	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
04/02/2022	16:03	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	USOTC:AURX	Nuo Therapeutics Inc (QB)
21/01/2022	10:29	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	USOTC:AURX	Nuo Therapeutics Inc (QB)
09/10/2020	14:30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:AURX	Nuo Therapeutics Inc (QB)
13/11/2019	15:32	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
17/04/2019	15:21	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
04/08/2017	15:02	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:AURX	Nuo Therapeutics Inc (QB)
30/06/2017	16:25	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
20/04/2017	13:14	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AURX	Nuo Therapeutics Inc (QB)
11/04/2017	05:17	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:AURX	Nuo Therapeutics Inc (QB)